Evidence map›Paper›PMID 35745321›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Automated Quantum Dots Purification via Solid Phase Extraction.

Malín G Lüdicke, Jana Hildebrandt, Christoph Schindler, Ralph A Sperling, Michael Maskos

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Malín G LüdickeFraunhofer Institute for Microengineering and Microsystems IMM, 55129 Mainz, Germany.ORCID 0000-0003-3994-1556
Jana HildebrandtFraunhofer Institute for Microengineering and Microsystems IMM, 55129 Mainz, Germany.
Christoph SchindlerFraunhofer Institute for Microengineering and Microsystems IMM, 55129 Mainz, Germany.
Ralph A SperlingFraunhofer Institute for Microengineering and Microsystems IMM, 55129 Mainz, Germany.
Michael MaskosFraunhofer Institute for Microengineering and Microsystems IMM, 55129 Mainz, Germany.
Fraunhofer Institute for Microengineering and Microsystems · DEFederal Institute For Materials Research and Testing · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The separation of colloidal nanocrystals from their original synthesis medium is an essential process step towards their application, however, the costs on a preparative scale are still a constraint. A new combination of approaches for the purification of hydrophobic Quantum Dots is presented, resulting in an efficient scalable process in regard to time and solvent consumption, using common laboratory equipment and low-cost materials. The procedure is based on a combination of solvent-induced adhesion and solid phase extraction. The platform allows the transition from manual handling towards automation, yielding an overall purification performance similar to one conventional batch precipitation/centrifugation step, which was investigated by thermogravimetry and gas chromatography. The distinct miscibility gaps between surfactants used as nanoparticle capping agents, original and extraction medium are clarified by their phase diagrams, which confirmed the outcome of the flow chemistry process. Furthermore, the solubility behavior of the Quantum Dots is put into context with the Hansen solubility parameters framework to reasonably decide upon appropriate solvent types.

Indexed as

flow chemistrypurificationquantum dotssolid phase extraction

Identifiers

PMID35745321
PMCPMC9230973
OpenAlexW4282839466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.